Related Experiment Video
Updated: Nov 28, 2025
09:19
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
9.4K
[Thromboembolic Complications in COVID-19]
Stephanie Müller1, Jan Beyer-Westendorf1
1Medizinische Klinik 1, Bereich Hämatologie und Hämostaseologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden.
Deutsche Medizinische Wochenschrift (1946)
|November 30, 2020
Summary
This review examines the thromboembolic risk in COVID-19 patients, offering guidance on thromboprophylaxis and interpreting abnormal coagulation tests. It addresses challenges in clinical routines and diagnostic pathways posed by the novel coronavirus disease.
Area of Science:
- Internal Medicine
- Hematology
- Infectious Diseases
Background:
- COVID-19 presents unprecedented clinical challenges, impacting established routines and diagnostic processes.
- Understanding the thromboembolic risk associated with COVID-19 is critical for patient management.
- Abnormal coagulation tests in COVID-19 patients require careful interpretation.
Purpose of the Study:
- To review current evidence on thromboembolic risk in COVID-19.
- To discuss recommendations for thromboprophylaxis in these patients.
- To explore the significance of abnormal coagulation tests and present practical solutions.
Main Methods:
- Literature review of current evidence on COVID-19 and thromboembolism.
- Analysis of pathophysiological concepts related to coagulation.
- Synthesis of current guidance and recommendations for clinical practice.
Main Results:
- COVID-19 is associated with a significant thromboembolic risk.
- Specific recommendations for thromboprophylaxis are provided.
- The relevance and interpretation of abnormal coagulation tests are discussed.
Conclusions:
- Effective management of COVID-19 requires addressing thromboembolic risks.
- Timely thromboprophylaxis and appropriate interpretation of coagulation tests are essential.
- Guidance is provided to navigate diagnostic and clinical challenges posed by COVID-19.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
135
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
135
01:29Pulmonary Embolism I: Introduction
294
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
294
01:29Venous Thrombosis III: Interprofessional Care
139
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
139
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
129
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
129
01:27Pulmonary Embolism III: Nursing Management
150
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
150
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
142
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
142